Zivo Bioscience director sells shares valued at $325

Published 10/04/2025, 02:44
Zivo Bioscience director sells shares valued at $325

Christopher D. Maggiore, a director and significant shareholder of Zivo Bioscience, Inc. (NASDAQ:ZIVO), recently executed a sale of company shares. According to the latest SEC filing, Maggiore sold 20 shares of common stock on April 8, 2025, at a price of $16.25 per share, totaling $325. Following this transaction, Maggiore holds 507,000 shares in the company, representing a significant stake in this $60 million market cap biotechnology firm. The stock, which has declined nearly 20% over the past six months, currently trades near InvestingPro's Fair Value estimate. InvestingPro analysis reveals the stock typically moves opposite to broader market trends, making it an interesting diversification option. Subscribers can access 8 additional key insights about ZIVO on InvestingPro.

In other recent news, Zivo Bioscience has reported the issuance of new equity shares, raising approximately $1.5 million. According to a recent 8-K filing with the Securities and Exchange Commission, the company sold 75,000 shares to one accredited investor at a price of $20.19 per share. Additionally, Zivo Bioscience has granted 38,478 shares as restricted stock to non-employee members of its board of directors under its 2024 Equity Incentive Plan. In a related development, the company announced an Exchange Program, issuing 78,320 shares to certain investors in exchange for the cancellation of specific agreements and associated revenue-sharing arrangements. These transactions were conducted privately, without public offerings or general solicitation, and were not registered under the Securities Act of 1933. Instead, they were offered to accredited investors under specific exemptions. As of January 22, 2025, Zivo Bioscience has a total of 3,738,033 shares of common stock outstanding.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.